Identification of meningococcal LPS as a major monocyte activator in IL-10 depleted shock plasmas and CSF by blocking the CD14-TLR4 receptor complex

Abstract

We have examined the in vitro stimulatory effects of lipopolysaccharide (LPS)-containing samples (meningococcal shock plasma, n = 10; non-shock plasma, n = 10; cerebrospinal fluid (CSF), n = 7) before and after immunodepletion of interleukin (IL)-10 in a monocyte target assay. We also studied the stimulatory effects of plasma collected from 3 patients with lethal septicemia caused by Streptococcus pneumoniae without detectable LPS but with 100-fold increased levels of heat-shock protein 70 (HSP70). HSP70 may, like LPS, activate monocytes via the Toll-like receptor 4 (TLR4). The samples were analyzed for LPS, tumor necrosis factor (TNF)-α, IL-10 and HSP70; applied on human monocytes (purity > 95%) before and after IL-10 immunodepletion, in the absence or presence of CD14 blocking mAb (60bca) or the lipid A antagonist, Rhodobacter sphaeroides diphosphoryl lipid A (RsDPLA) which blocks TLR4. Monocyte activation was measured by increased TNF-α secretion and tissue factor (TF) up-regulation by monocyte procoagulant activity (PCA). There was a positive correlation between patientplasma LPS levels (n = 10) and increases in TNF-α secretion by the monocytes after immunodepletion of IL-10 ( r = 0.82). Pretreatment of the monocytes with mAbCD14 or RsDPLA reduced TNF-α secretion to median 5% and 12%, respectively, of the levels before the receptor complex was blocked. The median levels of HSP70 were 543 ng/ml (range, 468—962 ng/ml) in pneumococcal shock plasma, 81.5 ng/ml (range, 41—331 ng/ml) in meningococcal shock plasma and 24 ng/ml (range, < 0.8—41 ng/ml) in meningococcal non-shock plasma. Pneumococcal septic shock plasmas with significantly higher levels of HSP70 (P < 0.05) did not induce TNF-α secretion in the monocytes. The results strongly suggest that LPS in meningococcal shock plasma is the major activator of monocytes whereas HSP70 (in plasma concentrations up to 963 ng/ml) does not activate monocytes in this assay.

References

Brandtzaeg P. , Kierulf P. , Gaustad P. et al. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 1989; 159: 195—204.

Brandtzaeg P, vstebø R, Kierulf P. Bacteremia and compartmentalization of LPS in meningococcal disease. In: Levin J , Alving CR , Munford RS , Redl H. (eds) Bacterial Endotoxins, Lipopolysaccharides from Gene to Therapy . New York: Wiley-Liss, 1995;219-233.

Brandtzaeg P. , Bjerre A. , vstebø R. , Brusletto B, Joø , KierulfP. Neisseria meningitidis lipopolysaccharides in human pathology. J Endotoxin Res 2001; 7: 401—420.

Holst O. , Ulmer AJ , Brade H. , Flad HD , Rietschel ET Biochemistry and cell biology of bacterial endotoxins. FEMS Immunol Med Microbiol 1996; 16: 83—104.

Brandtzaeg P. , vstebø R. , Kierulf P. Quantitative detection of bacterial lipopolysaccharides in clinical specimens . In: Pollard AJ , Maiden MCJ. (eds) Meningococcal Disease Protocols . Totowa, NJ: Humana, 2001;427-439.

van Deuren M. , Brandtzaeg P. , Der Meer JW Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 2000 ; 13: 144—166.

Uronen H. , Williams AJ , Dixon G. et al. Gram-negative bacteria induce proinflammatory cytokineproductionby monocytes in the absence of lipopolysaccharide (LPS). Clin Exp Immunol 2000; 122: 312—315.

Ingalls RR , Lien E. , Golenbock DT Differential roles of TLR2 and TLR4 in the host response to Gram-negative bacteria: lessons from a lipopolysaccharide-deficient mutant of Neisseria meningitidis. J Endotoxin Res 2000; 6: 411—415.

Pridmore AC , Wyllie DH , Abdillahu F. et al. A lipopolysaccharide-deficient mutant of Neisseria meningitidis elicits attenuated cytokine release by human macrophages and signals via Toll-like receptor (TLR) 2 but not via TLR4/MD2. J Infect Dis 2001; 183: 89—96.

10.

Sprong T. , StikkelbroeckN. , van der Ley P. et al. Contributions of Neisseria meningitidis LPS and non-LPS to proinflammatory cytokine response. J Leukoc Biol 2001; 70: 283—288.

11.

Steeghs L. , den Hartog R. , den Boer A. , Zomer B. , Roholl P. , van der Ley P. Meningitis bacterium is viable without endotoxin [letter]. Nature 1998; 392: 449—450.

12.

Lorenzen DR , Düx F. , Wölk U. , Tsirpouchtsidis A. , Haas G. , Meyer TF ImmunoglobulinAl protease, an exoenzyme of pathogenic Neisseriae, is a potent inducer of proinflammatory cytokines. J Exp Med 1999; 190: 1049—1058.

13.

Henderson B. , Poole S. , Wilson M. Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev 1996; 60: 316—341.

14.

Zhang H. , Peterson JW , Niesel DW , Klimpel GR Bacterial lipoprotein and lipopolysaccharide act synergistically to inducelethal shock and proinflammatory cytokine production. J Immunol 1997; 159: 4868—4878.

15.

Yi AK , Yoon JG , Hong SC , Redford TW , Krieg AM Lipopolysaccharide and CpG DNA synergize for tumor necrosis factor-alpha production through activation of NF-kappaB. Int Immunol 2001; 13: 1391—1404.

16.

Schumann RR , Leong SR , Flaggs GW et al. Structure and function of lipopolysaccharide binding protein. Science 1990; 249: 1429—1431.

17.

WrightSD , Ramos RA , Tobias PS , Ulevitch RJ , Mathison JC CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431—1433.

18.

Lien E. , Means TK , Heine H. et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest 2000; 105: 497—504.

19.

Lien E. , Ingalls RR Toll-like receptors. Crit Care Med 2002; 30: S1—S11.

20.

Dybdahl B. , Wahba A. , Lien E. et al. Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through Toll-like receptor-4. Circulation 2002; 105: 685—690.

21.

Delogu G. , Lo Bosco L , Marandola M. et al. Heat shock protein (HSP70) expression in septic patients. J Crit Care 1997; 12: 188—192.

22.

Schroeder S. , Bischoff J. , Lehmann LE et al. Endotoxin inhibits heat shock protein 70 (HSP70) expression in peripheral blood mononuclear cells of patients with severe sepsis. Intensive Care Med 1999; 25: 52—57.

23.

Villar J. , Ribeiro SP , Mullen Jbm et al. Induction of the heat shock response reduces mortality rate and organ damage in a sepsis-induced acute lung injury model. Crit Care Med 1994; 22: 914—921.

24.

Ribeiro SP , Villar J. , Downey GP , Edelson JD , Slutsky AS Sodium arsenite induces heat shock protein-72 kilodalton expression in the lungs and protects rats against sepsis. Crit Care Med 1994; 22: 922—929.

25.

Derkx B. , Marchant A. , Goldman M. , Bijlmer R. , van Deventer S. High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock. J Infect Dis 1995 ; 171: 229—232.

26.

van Deuren M. , van der Ven-Jongekrijg J. , Bartelink Akm , van Dalen R. , Sauerwein RW , van der Meer Jwm. Correlation between proinflammatory cytokines and anti-inflammatory mediators and the severity of disease in meningococcal infections. J Infect Dis 1995; 172: 433—439.

27.

Lehmann AK , Halstensen A. , Sornes S. , Rokke O. , Waage A. High levels of interleukin 10 in serum are associated with fatality in meningococcal disease. Infect Immun 1995 ; 63: 2109—2112.

28.

de Waal MR , Abrams J. , Bennett B. , Figdor CG , de Vries JE Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209—1220.

29.

Gerard C. , Bruyns C. , Marchant A. et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993; 177: 547—550.

30.

van der PT , de Waal MR , Coyle SM , Lowry SF Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13. J Infect Dis 1997; 175: 118—122.

31.

Pradier O. , Gerard C. , Delaux A. et al. Interleukin-10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharide. Eur J Immunol 1993; 23: 2700—2703.

32.

Brandtzaeg P. , Osnes L. , vstebø R. , Joø GB , Westvik Å B. , Kierulf P. Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes [published erratum appears in J Exp Med 1996; 184: 2075]. J Exp Med 1996 ; 184: 51—60.

33.

Osnes LT , Westvik AB , KierulfP. Procoagulant and profibrinolytic activities of cryopreserved human monocytes. Thromb Res 1994; 76: 373—383.

34.

Caugant DA , Høiby EA , Magnus P. et al. Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease. Proc Natl Acad Sci USA 1986; 83: 4927—4931.

35.

Bjerre A. , Brusletto B. , Rosenquist E. et al. Cellular activating properties and morphology of membrane-bound and purified meningococcal lipopolysaccharide. J Endotoxin Res 2000; 6: 437—445.

36.

Osnes L. , Westvik Å.B. , vstebø R. , Joø GB , Okkenhaug C. , KierulfP. Lipopolysaccharide activation of human monocytes mediated by CD14, results in coordinated synthesis of tissue factor, TNF-α and IL-6. J Endotoxin Res 1995; 2: 27—35.

37.

Jungi TW A turbidimetric assay in an ELISA reader for the determination of mononuclear phagocyte procoagulant activity. J Immunol Methods 1990; 133: 21—29.

38.

Takayama K. , Qureshi N. , Beutler B. , Kirkland TN Diphosphoryllipid A from Rhodopseudomonassphaeroides ATCC 17023 blocks induction of cachectin in macrophages by lipopolysaccharide . Infect Immun 1989; 57: 1336—1338.

39.

Asea A. , Kraeft SK , Kourt-Jones EA et al. HSP70 stimulates cytokine production through a CD14-dependantpathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 2000; 6: 435—442.

40.

Wright BH , Corton JM , El Nahas AM, Wood RF, Pockley AG. Elevated levels of circulating heat shock protein 70 (Hsp70) in peripheral and renal vascular disease. Heart Vessels 2000; 15: 18—22.

41.

Hashiguchi N. , Ogura H. , Tanaka H. et al. Enhanced expression of heat shock proteins in activated polymorphonuclear leukocytes in patients with sepsis. J Trauma 2001; 51: 1104—1109.

42.

Ingalls RR , Lien E. , Golenbock DT Membrane-associated proteins of a lipopolysaccharide-deficient mutant of Neisseria meningitidis activate the inflammatory response through Toll-like receptor 2. Infect Immun 2001; 69: 2230—2236.